Prevalence of eye disorder high among older US adults with diabetes

August 10, 2010

Nearly 30 percent of U.S. adults with diabetes over the age of 40 are estimated to have diabetic retinopathy, with about 4 percent of this population having vision-threatening retinopathy, according to a study in the August 11 issue of JAMA.

Diabetic retinopathy (damage to the retina caused by complications of diabetes mellitus) is the leading cause of new cases of legal blindness among adults 20 to 74 years of age in the United States. Diabetes-related blindness costs the United States approximately $500 million annually, according to background information in the article. "Investigating the prevalence of diabetic retinopathy is important because it is a key indicator of systemic diabetic microvascular complications, and as such, a sentinel indicator of the impact of diabetes," the authors write.

Xinzhi Zhang M.D., Ph.D., of the Centers for Disease Control and Prevention, Atlanta, and colleagues conducted a study to determine the most recent prevalence and risk factors of diabetic retinopathy in the U.S. population ages 40 years and older. The study included an analysis of data from a nationally representative sample of the National Health and Nutrition Examination Survey 2005-2008 and included 1,006 individuals. Diabetes was defined as a self-report of a previous diagnosis of the disease (excluding gestational diabetes mellitus) or glycated hemoglobin A1c (a form of hemoglobin used primarily to identify the average plasma glucose concentration) of 6.5 percent or greater. Photographs were taken of each eye to determine and classify diabetic retinopathy. Prevalence estimates were weighted to represent the civilian, noninstitutionalized U.S. population 40 years of age and older.

The researchers found that from 2005-2008 the estimated prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was 28.5 percent and 4.4 percent, respectively, among persons with diabetes ages 40 years and older. Approximately 31.6 percent of men and 25.7 percent of women with diabetes had diabetic retinopathy.

Also, 26.4 percent of non-Hispanic white individuals, 38.8 percent of non-Hispanic black individuals, and 34.0 percent of Mexican American individuals with diabetes had diabetic retinopathy. Approximately 3.2 percent of non-Hispanic white individuals, 9.3 percent of non-Hispanic black individuals and 7.3 percent of Mexican American individuals with diabetes had vision-threatening diabetic retinopathy.

Further analysis indicated that independent risk factors for diabetic retinopathy include male sex (38.1 percent vs. 27.1 percent), higher hemoglobin A1c level, longer diabetes duration, use of insulin (47.4 percent vs. 26.7 percent), and higher systolic blood pressure.

"These estimates provide policy makers updated information for use in planning eye care services and rehabilitation. With the aging of the population and the increasing proportion of the population with diverse racial/ethnic heritage, the number of cases of diabetic retinopathy and vision-threatening diabetic retinopathy will likely increase. Furthermore, the need for eye care and for culturally appropriate interventions that can reduce disparity and improve access to eye care among diverse populations is also likely to increase," the authors conclude.
-end-
(JAMA. 2010;304[6]:649-656. Available pre-embargo to the media at www.jamamedia.org)

Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

The JAMA Network Journals

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.